by Eclosion Team | Feb 22, 2018 | Uncategorized
Geneva, Switzerland, 22 February, 2018 – 6:30pm CET – GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurological and autoimmune diseases, announced today that GNbAC1 received Orphan Drug Designation...
by Eclosion Team | Feb 20, 2018 | Uncategorized
Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today that data in a preclinical model showed that GKT831, the Company’s NOX1 and NOX4 inhibitor, efficiently targeted cancer...